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Phosphorylation of Ezrin T567 plays an important role in eight-cell embryo compaction. Yet, it is not clear
how Ezrin phosphorylation is regulated during embryo compaction. Here, we demonstrated that inhibition
of Mek/Erk or protein kinase C (PKC) signaling reduced the phosphorylation level of Ezrin T567 in eight-cell
compacted embryos. Interestingly, the Rho GTPase inhibitor C3-transferase caused basolateral enrichment
of atypical PKC (aPKC), as well as basolateral shift of phosphorylated Ezrin, suggesting aPKC may be a key
regulator of Ezrin phosphorylation. Moreover, inhibition of PKC, but not Mek/Erk or Rho GTPases, affected
the maintenance of Ezrin phosphorylation in compacted embryos.We further identiﬁed that aPKC is indeed
required for Ezrin phosphorylation in eight-cell embryos. Taken together, Rho GTPases facilitate the apical
distribution of aPKC and Ezrin. Subsequently, aPKC and Mek/Erk work together to promote Ezrin
phosphorylation at the apical region, which in turn mediates the apical enrichment of ﬁlamentous actin,
stabilizing the polarized apical region and allowing embryo compaction. Our data also suggested that aPKC
might be the Ezrin kinase during eight-cell embryo compaction.
& 2013 Elsevier Inc. All rights reserved.Introduction
During mouse preimplantation embryogenesis, the ﬁrst cell dif-
ferentiation event leads to the segregation of the inner cell mass
(ICM) and the trophectoderm (TE), which initiates after the compac-
tion of blastomeres at the late eight-cell stage. Upon compaction,
blastomeres become polarized (Ducibella and Anderson, 1975;
Johnson and Ziomek, 1981; Lehtonen, 1980; Ziomek and Johnson,
1980). A polarized blastomere can give rise to two polarized outside
cells through symmetric division, or one apolar inside cell and one
polarized outside cell through asymmetric division. Subsequently,
inside cells and outside cells develop into the ICM and the TE,
respectively (Chen et al., 2010; Cockburn and Rossant, 2010;
Johnson, 2009; Johnson and McConnell, 2004; Zernicka-Goetz et al.,
2009). Cell polarization appears to be a critical factor for the cell fate
choice. Down-regulation of polarity molecules, such as PAR3 and thell rights reserved.
cheng@sibs.ac.cn (H. Cheng),
nzhi Li authors contributedatypical protein kinase C (aPKC), promotes inside localization of
blastomeres and the ICM fate (Plusa et al., 2005).
Many proteins have been shown to participate in eight-cell
blastomere polarization, including apically distributed JAM1, the
polarity protein PAR3 and PAR6, aPKC, Erk2, Ezrin and ﬁlamen-
tous actin (F-actin), as well as basolaterally localized PAR1 and E-
cadherin (Louvet et al., 1996; Lu et al., 2008; Pauken and Capco,
2000; Thomas et al., 2004; Vestweber et al., 1987; Vinot et al.,
2005). Ezrin is a member of the ERM (Ezrin, Radixin, Moesin)
protein family, which serves as cross-linkers between F-actin and
the plasma membrane (Chen et al., 1995; Kondo et al., 1997;
Lamb et al., 1997; Martin et al., 1995; Takeuchi et al., 1994). The
cross-linker function of Ezrin requires the phosphorylation of
T567. In resting cells, Ezrin is in a dormant state, where the
F-actin binding site is masked through the interaction between
the N-terminal ERM homology (FERM) domain and the C-terminal
tail domain. Phosphorylation of Ezrin T567 disrupts the interac-
tion between the FERM and tail domains, exposing the F-actin
binding site (Bretscher et al., 2002; Matsui et al., 1998; Shaw
et al., 1998; Simons et al., 1998). Ezrin is expressed throughout
preimplantation embryo development. It is distributed evenly
around the cell cortex from the zygote to the early eight-cell
stage, and becomes restricted to the apical region after compac-
tion (Louvet et al., 1996). It has been suggested that blastomere
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post-translational modiﬁcations, but not protein synthesis (Bloom
and McConnell, 1990; Kidder and McLachlin, 1985; Levy et al.,
1986). Consistently, phosphorylation of Ezrin T567 plays an
important role in the compaction and the polarization of eight-
cell embryos (Dard et al., 2004). The mutation of T567 into an
aspartate (T567D), mimicking a phosphorylated residue, renders
Ezrin to localize all around the cell cortex, instead of polarized
apical distribution in eight-cell embryos. Consequently, the com-
paction of eight-cell embryos and the blastocoel formation in
blastocysts are compromised by the Ezrin-T567D mutation.
Oppositely, replacing T567 by an alanine (T567A), which prevents
phosphorylation at this residue, does not affect compaction at the
eight-cell stage. However, developmental defect is observed at
the 16-cell stage and later, due to the aberrant redistribution of
the Ezrin-T567A mutant to the basolateral cortex and reduced
surface of adherens junctions (Dard et al., 2004).
Moreover, some signaling molecules, such as PKC, Mek/Erk and
Rho family GTPases, are also involved in blastomere polarization and
compaction of the eight-cell embryo (Clayton et al., 1999; Lu et al.,
2008; Maekawa et al., 2007; Winkel et al., 1990). Both PKCz and
Erk2 show apical distribution in compacted eight-cell embryos
(Lu et al., 2008; Pauken and Capco, 2000). Moreover, activation of
PKC by phorbol ester leads to premature compaction at the four-cell
stage, while inhibition of PKC with sphingosine blocks induced
premature compaction as well as normal compaction of eight-cell
embryos (Winkel et al., 1990). Mek/Erk signaling has been suggested
to activate Cdx2 and to suppress Nanog, thereby regulating the
differentiation of the ICM and the TE (Lu et al., 2008). Yet, the
functional signiﬁcance of the apical distribution of Erk2 in late eight-
cell embryos remains unclear. Is it the cause or the consequence of
blastomere polarization? Although there is no evidence for asym-
metric distribution of Rho GTPases in eight-cell embryos, it has been
demonstrated that Rho GTPases are required for blastomere polar-
ization and eight-cell embryo compaction (Clayton et al., 1999).
Even though many molecules involved in eight-cell blastomere
polarization have been identiﬁed, the genetic and biochemical
interactions of these molecules remain elusive. Here, we demon-
strated that Mek/Erk, PKC and Rho GTPases regulate Ezrin T567
phosphorylation through different mechanisms. Rho GTPases
regulate the distribution of aPKC, Ezrin and phosphorylated Ezrin
(p-Ezrin). Both aPKC and Mek/Erk signaling are required for Ezrin
T567 phosphorylation during embryo compaction. aPKC appears
to be the Ezrin kinase in eight-cell embryos. Phosphorylation of
Ezrin T567 in turn mediates the formation of F-actin at the apical
surface, and promotes embryo compaction. Thus, our studies
reveal a pivot role of Ezrin in eight-cell blastomere polarization
and embryo compaction, as well as the regulation of Ezrin
phosphorylation by multiple signaling pathways.Materials and methods
Cell culture
V6.5 and iRasES Embryonic stem (ES) cells were cultured
in Dulbecco’s modiﬁed Eagle’s medium (high glucose DMEM,
GIBCO), supplemented with 15% fetal bovine serum (FBS,
Hyclone), 2 mM L-glutamine, 5000 U/ml penicillin and strepto-
mycin, 0.1 mM nonessential amino acids (Invitrogen), 0.1 mM
2-mercaptoethanol (Sigma), and 1000 U/ml LIF (ESGRO, Chemi-
con). To induce Ras expression, iRasES cells were plated on
gelatin-coated tissue culture dish in mouse ES medium supple-
mented with 1 mg/ml doxycycline. ES-derived trophectoderm
stem (ES–TS) cells (Lu et al., 2008) and trophectoderm stem (TS)
cells were cultured in TS culturing medium containing RPMI1640, 20% FBS (Hyclone), Fgf4 (25 ng/ml), heparin (1 ng/ml),
0.1 mM 2-mercaptoethanol, 1 mM sodium pyruvate, 2 mM L-
glutamine, penicillin and streptomycin (Invitrogen).
Phosphoproteomic analysis with mass spectrometry
Ras expression was induced in iRasES cells with 1 mg/ml
doxycycline (Dox). Cells were harvested at indicated time points,
and phosphoproteins were puriﬁed with Phosphoprotein Puriﬁca-
tion Kit (Qiagen). LC–MS/MS analysis was performed with the
ThermoElectron Finnigan LTQ by the mass spec core facility in the
Institute of Biochemistry and Cell Biology, Chinese Academy of
Sciences, Shanghai.
Embryo culture
Female ICR mice (4–6 weeks) were induced to superovulate by
intraperitoneal injections of 5 IU of pregnant mare serum gonado-
tropin (PMSG, Calbiochem) and 48 h later 5 IU human chorionic
gonadotropin (hCG, Sigma). Then females were paired with ICR
males overnight and checked for vaginal plugs the following
morning. Two-cell embryos were ﬂushed from oviducts at 42–48 h
post-hCG and cultured in groups of 20–30 in a 50 mL droplet of
potassium simplex optimization medium (KSOM) with amino acids
(Millipore) covered by mineral oil (Sigma, for embryo culture) in a
37 1C incubator with 6.5% CO2. Inhibitors were added at appropriate
stages at the following concentrations: PD98059 (Calbiochem),
20 mM; PD0325901 (Sigma), 1 mM; C3-transferase (Cytoskeleton),
1 mg/ml; H-1152 (Calbiochem), 1 mM; cytochalasin D (Calbiochem),
0.5 mg/ml; D-Sphingosine (Sigma), 2.5 mM; Ro-31-8220 (Calbio-
chem), 5 mM; Go¨ 6976 (Calbiochem), 1 mM; PKCz pseudosubstrate
inhibitor (Myristoylated-SIYRRGARRWRKL-OH, Calbiochem), 10 mM.
All experiments were performed with groups of more than 10
embryos and repeated three times.
Immunoﬂuorescence
Embryos at desired stages were ﬁxed in 4% paraformaldehyde for
20 min, and then permeabilized with 0.2% Triton X-100 for 30min.
After being blocked with 5% goat serum for 2 h, embryos were
incubated with primary antibodies for 4–6 h at room temperature
or overnight at 4 1C. Then embryos were washed and incubated with
secondary antibodies and/or rhodamine-phalloidin (Molecular Probe).
We used the following primary antibodies: anti-Ezrin (BD Transduc-
tion Laboratories), phospho-Ezrin (Thr567)/Radixin (Thr564)/Moesin
(Thr558) antibody (Cell Signaling Technology), anti-E-Cadherin (BD
Transduction Laboratories), anti-aPKC (Santa Cruz). We used Alexa
Fluor 488 anti-mouse, Alexa Fluor 488 anti-rabbit and Alexa Fluor
594 anti-rabbit as secondary antibodies (Molecular Probe), and
Hoechst 33342 (Sigma) for nuclei staining. Epiﬂuorescent images
were taken with Olympus IX81 microscope. Confocal images were
captured using Leica TCS SP5 confocal microscope.
Western blot
Cells were lysed, and total protein concentration was mea-
sured using BCA Protein Assay Kit (Beyotime) to ensure equal
loading in western blot analysis. The samples were resolved
by SDS-PAGE followed by transferring onto a PVDF membrane
(Millipore). Membranes were probed with anti-phospho-ERM
antibody (Cell Signaling Technology), anti-Ezrin (Sigma), anti-
Ras (Upstate), and anti-Actin (Abcam). Bound primary antibodies
were recognized by HRP-linked secondary antibodies (GE Health-
care). HRP activity was detected by ECL Plus (Beyotime) and
Kodak light ﬁlm. For protein lysates from embryos, pools of
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10 min, followed by SDS-PAGE.
Real-time RT-PCR
Total RNA was extracted from pools of embryos using RNeasy
Micro Kit (Qiagen) with an on-column DNA digestion using RNase-
Free DNase Set (Qiagen). cDNA synthesis was performed using
QuantiTect Reverse Transcription Kit (Qiagen) according to the
manufacturer’s instruction. Transcript levels were determined by
real-time PCR using SYBR Green Real-time PCRMaster Mix (TOYOBO)
in BioRad iQ5 system. Running conditions were as follows: 95 1C for
2min, 40 cycles of 95 1C for 15 s, 58 1C for 15 s, and 72 1C for 30 s,
and then a melting curve of the ampliﬁed DNA was acquired.
Quantiﬁcation of target genes was normalized with b-Actin. Primer
sequences were as follows: Ezrin forward GAAAGGAACAGAC-
CTTTGGCTTGG, Ezrin reverse GCCTTCTTGTCGATGGGCTTAATG; b-
Actin forward CAGAAGGAGATTACTGCTCTGGCT, b-Actin reverse
TACTCCTGCTTGCTGATCCACATC; PKCl forward CATCCAGACCACACA-
CAGACAGTA, PKCl reverse AAATCCTGCAGACCTAGACTGGAC; PKCz
forward GCCTCCAGTAGATGACAAGAACGA, PKCz ATCGATGACAGG-
CTTAAGGTCCTC; PKCl/z forward CAGAGAAGCATGTGTTTGAGCAGG,
PKCl/z reverse CGCTGCATATGAAACATGAGGTCC.
Transfection of TS cells
Short interfering RNAs (siRNA) were synthesized by GenePharma
Shanghai Corp. siRNA was transfected into TS cells at 70% conﬂuence
with Lipofectamine 2000 (Invitrogen) according to themanufacturer’sFig. 1. Phosphorylation of Ezrin T567 was associated with trophectodermal differentiat
(p-Ezrin), while the expression of Ezrin remained steady. (B) Immunoblot analysis reve
cells. However, the levels of p-Ezrin in ES–TS and TS cells were signiﬁcantly higher than
blastocyst stage. Phosphorylated Ezrin became detectable in compacted eight-cell embr
maintained throughout preimplantation embryogenesis. Hoechst 33342 staining markinstruction. 24 h later, cells were harvested. RNA was puriﬁed and
subjected to real-time RT-PCR analysis. The siRNA sequences were as
follows: PKCl-1 GGGAAGACAAGTCCATTTA; PKCl-2 CGCGTTCTCTGT-
CTGTAAA; PKCz-1 CAGGAGGCATATGGATTCT; PKCz-2 GGTGCAGA-
CAGAGAAACAT; PKCz-3 CCAGATCACAGATGACTAT.
Two-cell embryo injection
For embryo injection, 2-cell embryos were collected from
superovulated F1 females mated with F1 males (both C57BL/
6xDBA). 10 mM control or PKC siRNAs, together with 0.03 mg/ml
H2B-Cherry mRNA, were injected into one blastomere of late 2-
cell stage mouse embryos. Microinjection was performed in M2
medium on a Leica DMI3000B inverted microscope equipped with
Leica micromanipulator and Eppendorf FemtoJet microinjector as
described elsewhere (Na et al., 2007). After injection, embryos
were cultured until the 8-cell stage in KSOMmedium in incubator
at 37 1C supplied with 5% CO2.Results
Ezrin becomes phosphorylated upon Ras induction in ES cells
It has been demonstrated that ectopic expression of an
activated form of human H-Ras (HRas1Q61L) in mouse embryonic
stem (ES) cells activates the Mek/Erk signaling pathway, which in
turn activates the key trophectodermal transcription factor Cdx2,
and suppresses the pluripotency gene Nanog, resulting in differ-
entiation toward trophectoderm (Lu et al., 2008). We utilized thision. (A) In iRasES cells, Ras induction increased the phosphorylation of Ezrin T567
aled that the expression levels of Ezrin were similar in V6.5 ES cells, ES–TS and TS
that in ES cells and (C) Confocal images of mouse embryos from the two-cell to the
yos, and was distributed in the apical region. The apical enrichment of p-Ezrin was
ed the nucleus. Bar, 20 mm.
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regulates the transcription of Nanog and Cdx2, as well as other
potential functions of Mek/Erk signaling in trophectodermal
differentiation. Mek/Erk signaling is transduced through a cascade
of kinases. Thus, we set out to identify proteins being phosphory-
lated after Ras induction. Inducible Ras ES (iRasES) cells were
harvested at 0, 12, and 24 h after Ras induction, and phospho-
proteins were puriﬁed and subjected to mass-spectrometry ana-
lysis. Proteins detected at 12 and/or 24 h, but not at 0 h, were
listed in supplemental Table S1.
Among these candidates, Ezrin was of particular interest for us.
Ezrin is one of the molecules involved in eight-cell blastomere
polarization. It is distributed evenly around the cell cortex before
the early eight-cell embryo stage, and becomes enriched at the
apical region after compaction (Louvet et al., 1996). Moreover,
phosphorylation of Ezrin at T567 has been shown to be critical for
eight-cell embryo compaction (Dard et al., 2004). We ﬁrst con-
ﬁrmed our mass-spectrometry result by western blot. Ras induc-
tion did not change Ezrin expression level signiﬁcantly, while
phosphorylated Ezrin was increased after Ras induction (Fig. 1A).
We further examined the expression of Ezrin and p-Ezrin in ES
cells, a trophectoderm stem cell line derived from iRasES cellsFig. 2. Inhibition of Mek/Erk reduced the level of p-Ezrin, but not total Ezrin in compacte
(20 mM) from the late two-cell stage to the compacted eight-cell stage for 24 h. (A) Epiﬂ
in PD98059 treated embryos, while the expression and the distribution of Ezrin in eigh
were shown for reference. The numbers in parentheses denote the fraction of embryos
represented in the image from three independent experiments, and the denominator i
images of PD98059 treated and control embryos stained for p-Ezrin. The level of p-Ezrin
in PD98059 treated embryos. b-Actin was used as a loading control. (D) Reverse trans
mRNA in eight-cell embryos was not changed by PD98059. (E) F-actin (stained by
distribution was not affected. (F, G) Inhibition of Mek/Erk did not change the apical po(ES–TS) and embryo-derived trophectoderm stem (TS) cells. More
p-Ezrin was detected in ES–TS and TS cells than in ES cells,
whereas Ezrin expression levels in all three types of cells were
similar (Fig. 1B). It implied that Ezrin phosphorylation might play
a role in the segregation of the TE and the ICM lineages.
Inhibition of Mek/Erk signaling blocks Ezrin phosphorylation in late
eight-cell embryos
To study the role of Ezrin phosphorylation in early embry-
ogenesis, we determined the expression dynamics of Ezrin and
the level of p-Ezrin during early embryo development. Consistent
with previous report, Ezrin expression was detected throughout
preimplantation embryo development. Ezrin was located at the
cell cortex before compaction, and became apically distributed in
compacted embryos (Louvet et al., 1996). In contrast, p-Ezrin was
not detected before the early eight-cell embryo stage. Clear apical
p-Ezrin staining appeared in compacted eight-cell embryos, and
was maintained in morula and blastocysts (Fig. 1C).
We have shown that Ezrin became phosphorylated upon Ras
induction in ES cells. Our previous study has identiﬁed Mek/Erk
signaling as a major downstream mediator of Ras during iRasES celld eight-cell embryos. Embryos were cultured in medium with or without PD98059
uorescent pictures showed that the level of apically localized p-Ezrin was reduced
t-cell embryos were not affected by PD98059. Hoechst staining and phase images
presented in this and all other ﬁgures. The numerator is the number of embryos
s the total number of embryos from three independent experiments. (B) Confocal
was decreased by PD98059 treatment. (C) Western blot detected reduced p-Ezrin
cription followed by real-time PCR analysis demonstrated that the level of Ezrin
phalloidin) formation was reduced in PD98059 treated embryos. Yet, its apical
larization of aPKC and the basolateral location of E-cadherin. Bar, 20 mm.
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then asked whether Mek/Erk signaling regulates Ezrin phosphoryla-
tion in developing embryos. Two-cell embryos were treated with the
Mek inhibitor PD98059 for 24 h, and the expression of p-Ezrin in the
resulting late eight-cell embryos was examined by immunostaining.
Inhibition of Mek/Erk signaling did not impair embryo compaction
(Fig. S1). However, p-Ezrin level decreased signiﬁcantly in PD98059
treated embryos, whereas the expression level and the apical
distribution of Ezrin were not affected by PD98059 (Fig. 2A and B).
Immunoblot assay further conﬁrmed that PD98059 treatment
blocked the phosphorylation of Ezrin (Fig. 2C). Due to the low afﬁnity
of Ezrin antibody, Ezrin expression in eight-cell embryos was
undetectable by western blot. Instead, Ezrin mRNA levels in
PD98059 treated and control embryos were measured by reverse
transcription followed by real-time PCR. Ezrin mRNA expression was
not affected by PD98059 treatment (Fig. 2D). To ensure that the
reduced p-Ezrin level is due to inhibition of Mek/Erk signaling, but
not non-speciﬁc effect of PD98059, we treated two-cell embryos with
another Mek inhibitor PD0325901. Consistently, 24-h treatment with
PD0325901 suppressed the phosphorylation of Ezrin in compacted
eight-cell embryos (Fig. S2). These data suggested that the Mek/Erk
signaling pathway is involved in phosphorylating Ezrin during
embryo compaction. When embryos were allowed to grow in the
medium without PD98059 for 3 h after the 24-h PD98059 treatment
from the two-cell to the eight-cell stage, the apical pattern of p-Ezrin
was recovered to the control level (Fig. S3). These data suggested that
the inhibitory effect of PD98059 on the unknown Ezrin kinase is
reversible. Moreover, Ezrin phosphorylation occurred within such a
short time window, implying that Mek inhibition might only affect
the activation of the unknown Ezrin kinase, but not its expression.Fig. 3. Embryo compaction and blastomere polarization were compromised by inhibit
1 mg/ml C3-transferase for 12 h. The resulting eight-cell embryos were immunostained f
the nucleus. Confocal images were shown. (A) The apical localization of Ezrin and p-
reduced in C3-transferase treated embryos. The bright green circles outside eight-cell e
control embryos were marked with arrows, while the basolateral Ezrin and p-Ezrin wer
cortex of C3-transferase treated embryos. (C) C3-transferase treatment led to basolater
not interfere the basolateral localization of E-cadherin. Bar, 20 mm.We further analyzed whether inhibition of Mek/Erk signaling
affects other polarized molecules in compacted embryos. The
basolateral distribution of E-cadherin and the apical localization
of aPKC and F-actin were not changed by PD98059 treatment
(Fig. 2E–G). However, the F-actin staining became attenuated in
PD98059 treated embryos, consistent with the fact that Ezrin
phosphorylation is required for the interaction between Ezrin and
F-actin (Fig. 2E). To distinguish whether apical enrichment of
F-actin is up-stream or down-stream of Ezrin phosphorylation, a
well-known microﬁlament-disrupting agent cytochalasin D (CCD)
was used to treat four-cell embryos. Shown in Fig. S2, CCD
treatment prevented embryo compaction. However, the overall
level of p-Ezrin in eight-cell embryos was not reduced by CCD
treatment. These data suggested that Ezrin phosphorylation is up-
stream of apical F-actin enrichment, and down-stream of Ezrin
and aPKC polarization during embryo compaction.
Rho GTPases regulate the distribution of Ezrin, p-Ezrin and aPKC
Rho-associated kinases, as well as PKCa, PKCl and PKCy, have
been shown to phosphorylate the conserved threonine in the ERM
proteins in vitro and in cultured cells (Chuan et al., 2006; Matsui
et al., 1998; Ng et al., 2001; Oshiro et al., 1998; Pietromonaco et al.,
1998; Shaw et al., 1998; Simons et al., 1998; Wald et al., 2008).
Coincidently, both Rho GTPases and PKC are involved in eight-cell
embryo compaction (Clayton et al., 1999; Winkel et al., 1990). Thus,
it raised the possibility that Rho GTPases or PKC might be the Ezrin
kinase in eight-cell embryos. To test whether Rho GTPases regulate
the phosphorylation of Ezrin T567 during embryo compaction, four-
cell embryos were treated with a Rho inhibitor C3-transferase forion of Rho GTPases. Four-cell embryos were cultured in medium with or without
or Ezrin and p-Ezrin, F-actin, aPKC and E-cadherin. Hoechst 33342 staining marked
Ezrin was impaired by C3-transferase. Moreover, the overall level of p-Ezrin was
mbryos were background signals of Zona pellucida. The apical Ezrin and p-Ezrin in
e highlighted with triangles. (B) F-actin colocalized with p-Ezrin in the basolateral
al distribution of aPKC, which overlapped with F-actin and (D) C3-transferase did
H. Liu et al. / Developmental Biology 375 (2013) 13–221812 h, and the resulting eight-cell embryos were subjected to
immunoﬂuorescence analysis. Consistent with previous report
(Clayton et al., 1999), 80% (69 out of 86) of embryos treated with
C3-transferase failed to compact (Fig. S1). Moreover, inhibition of
Rho GTPases reduced the overall level of p-Ezrin, and disrupted the
apical restriction of Ezrin and p-Ezrin. Ezrin and p-Ezrin were also
detected in the basolateral cortex in C3-transferase treated embryos
(Fig. 3A). In addition, F-actin and aPKC co-localized with p-Ezrin at
the basolateral cortex (Fig. 3B and C). These data implicated that Rho
GTPases regulate the spatial distribution of the Ezrin kinase in eight-
cell embryos. Inhibition of Rho GTPases changes the spatial pattern
of p-Ezrin, subsequently the distribution of F-actin. Co-localization
of aPKC and p-Ezrin at the basolateral region implied that aPKC
might be a candidate for Ezrin kinase or an associated factor of Ezrin
kinase. Treatment of four-cell embryos with another highly speciﬁc
and potent Rho kinase inhibitor (H-1152) recaptured the pheno-
types caused by C3-transferase, including reduced p-Ezrin level and
aberrant basolateral distribution of p-Ezrin in eight-cell embryos
(Fig. S2). These data further conﬁrmed that Rho GTPases are
involved in regulating the spatial distribution and the activity of
the Ezrin kinase in eight-cell embryos.
Inhibition of Rho GTPases affects not only Ezrin phosphorylation,
but also the microﬁlament cytoskeleton and the formation of the
apical region. Therefore, it is possible that the effect of Rho GTPase
inhibition on Ezrin phosphorylation is due to the disruption of the
microﬁlament cytoskeleton. However, disrupting microﬁlament
formation by CCD did not reduce the overall level of p-Ezrin or
affect the apically enriched p-Ezrin in eight-cell embryos, even
though the embryo compaction was blocked (Fig. S2). AlthoughFig. 4. The PKC inhibitor Ro-31-8220 reduced the level of p-Ezrin in compacted embryo
(A) Epiﬂuorescent images showed reduced expression of p-Ezrin and mis-organized F-a
31-8220 treatment did not change the localization of Ezrin, p-Ezrin, and aPKC. The brig
pellucida. (E) Ro 31-8220 treatment impaired E-cadherin exclusion from the apical regaberrantly basolaterally distributed p-Ezrin was also observed in
CCD treated embryos, incomplete blastomere polarization and the
failure of embryo compaction might be responsible for the appear-
ance of p-Ezrin at the basolateral region. These data suggested that
the regulatory effect of Rho GTPases on Ezrin phosphorylation is not
due to the disruption of the microﬁlament cytoskeleton.
PKC inhibition by Ro-31-8220 prevents Ezrin phosphorylation,
but does not alter the distribution of p-Ezrin
Next, we studied the potential role of PKC signaling in Ezrin
phosphorylation during embryo compaction. The PKC inhibitor Ro-
31-8220 was used to treat embryos from the two-cell stage. In
contrast to Rho kinase inhibition, inhibition of PKC by Ro-31-8220
affected neither eight-cell embryo compaction nor the distribution
of Ezrin and p-Ezrin (Figs. 4A, B, and S1). Instead, the overall level of
p-Ezrin was reduced by Ro-31-8220 treatment (Fig. 4A–C). Increas-
ing level of E-cadherin at the apical region in eight-cell embryos
(Fig. 4E), implying that PKC signaling might be involved in the
exclusion of E-cadherin from the apical domain. F-actin appeared
not to be well organized in Ro-31-8220 treated embryos (Fig. 4A, C).
This might be caused by non-speciﬁc effect of Ro-31-8220.
PKC activity is required for p-Ezrin maintenance in compacted
embryos
We have shown that Mek/Erk, Rho GTPases, and PKC regulate
Ezrin phosphorylation during eight-cell embryo development, and
that inhibition of Mek/Erk or PKC reduces the level of p-Ezrin ins. Two-cell embryos were cultured in medium with 5 mM Ro 31-8220 (Ro) for 24 h.
ctin in Ro 31-8220 treated embryos. (B–D) Confocal images demonstrated that Ro
ht green circles outside eight-cell embryos in (B) were background signals of Zona
ion. Bar, 20 mm.
Fig. 5. Inhibition of PKC after embryo compaction affected the maintenance of
p-Ezrin. Compacted eight-cell embryos were treated with 20 mM PD98059 (PD),
1 mM PD0325901 (PD-N), 1 mg/ml C3-transferase (C3), 1 mM H-1152 (H), 2.5 mM
sphingosine (Sph), or 5 mM Ro-31-8220 (Ro) for 3 h. The levels of p-Ezrin were
then detected by immunoﬂuorescence. Only inhibition of PKC by sphingosine or
Ro-31-8220 reduced the level of p-Ezrin. Bar, 20 mm.
H. Liu et al. / Developmental Biology 375 (2013) 13–22 19compacted eight-cell embryos. Yet, it is still unclear which kinase in
these two pathways phosphorylates Ezrin. We reasoned that the
Ezrin kinase should contribute to the establishment of Ezrin
phosphorylation during embryo compaction, as well as the main-
tenance of p-Ezrin in compact embryos. Thus, we asked which
pathway is responsible for the maintenance of p-Ezrin after embryo
compaction. Compacted eight-cell embryos, in which Ezrin has been
phosphorylated, were treated with Mek inhibitors PD98059 and
PD0325901, Rho kinase inhibitors C3-transferase and H-1152, and
PKC inhibitors sphingosine and Ro-31-8220, for 3 h. Immunoﬂuor-
escence assay revealed that inhibition of Mek/Erk and Rho GTPasesdid not affect the level of p-Ezrin in compacted embryos (Fig. 5).
However, inhibition of PKC by sphingosine or Ro-31-8220 sup-
pressed the phosphorylation of Ezrin (Fig. 5). These data implied
that PKC, but not Mek/Erk and Rho GTPases, is likely to be the Ezrin
kinase in compacted eight-cell embryos.
aPKC Is required for the phosphorylation of Ezrin in eight-cell
embryos
To further narrow down which subtype of PKC regulates Ezrin
phosphorylation, PKC inhibitors with subtype speciﬁcities were
used to treat two-cell embryos. Go¨ 6976, an inhibitor for PKCa
and PKCb, did not affect Ezrin phosphorylation in eight-cell
embryos (Fig. 6A). In contrast, a selective PKCz pseudosubstrate
inhibitor (Myristoylated-SIYRRGARRWRKL-OH, PSI) prevented
Ezrin phosphorylation in eight-cell embryos. The treatment with
PSI caused extensive embryo death, and only 6 out of 30 embryos
(20%) developed to the eight-cell embryo stage. Nevertheless,
these six surviving embryos all displayed similar phenotypes to
embryos treated with Ro-31-8220 (Fig. 6B). The level of p-Ezrin
was reduced, but the apical distribution of p-Ezrin was not
disturbed. These data not only conﬁrmed that PKC regulates Ezrin
phosphorylation in eight-cell embryos, but also implied that the
aPKC subtypes might be responsible for Ezrin phosphorylation in
eight-cell embryos.
To avoid the issue of non-speciﬁc effect associated with
inhibitors, siRNAs were applied to prove the regulation of Ezrin
phosphorylation by aPKC. The knockdown efﬁciencies of siRNAs
targeting PKCl or PKCz were ﬁrst tested in TS cells. As shown in
supplemental Fig. S4, two PKCl siRNAs downregulated PKCl
efﬁciently, whereas only siRNA z-2 knocked down PKCz to 50%.
Combination of siRNA l-1, l-2 and z-2 allowed simultaneous
downregulation of PKCl and PKCz. These siRNAs, together with
H2B-RFP mRNA, were injected into one blastomere of the two-cell
embryo. Injection of control, PKCl or PKCz siRNA individually did
not affect the level of p-Ezrin in progenies of the injected cell.
Only when both PKCl and PKCz were down-regulated, Ezrin
phosphorylation was reduced in the eight-cell blastomeres
derived from the injected cell (10 out of 40 injected embryos)
(Figs. 6C and S5). These data suggested that both subtypes of aPKC
phosphorylate Ezrin.Discussion
It has been demonstrated that spatial and temporal regulation
of Ezrin T567 phosphorylation is critical for embryo compaction
(Dard et al., 2004). Our data further support the importance of
Ezrin T567 phosphorylation in embryo compaction. When
embryos were treated with C3-transferase, Ezrin and p-Ezrin are
located to the basolateral region, and embryos fail to compact.
This phenotype is similar to the defect caused by Ezrin T567D
mutation, mimicking a phosphorylated state. Ezrin T567D mutant
localizes all around the cell cortex in eight-cell embryos, leading
to embryo compaction failure (Dard et al., 2004). Taken together,
abnormal p-Ezrin at the basolateral region, which might prevent
Ezrin from moving to the apical domain, initiates F-actin forma-
tion aberrantly at the basolateral region, interferes with tight
junction formation, and blocks embryo compaction. In contrast,
Ezrin T567A mutation does not impair embryo compaction.
Rather, Ezrin T567A mutant is almost cytoplasmic until the
eight-cell stage, and accumulates at the basolateral area in 16-
cell embryos, thus preventing further development of embryos
(Dard et al., 2004). These data suggest that unphosphorylated
Ezrin does not block embryo compaction. However, Ezrin phos-
phorylation is essential for anchoring Ezrin at the apical region,
Fig. 6. aPKC, but not PKCa/b, regulates Ezrin phosphorylation during embryo compaction. (A, B) Two-cell embryos were cultured in medium with 1 mM Go¨ 6976 (Go¨) or
10 mM PKCz pseudosubstrate inhibitor (PSI) for 24 h. (A) Inhibition of PKCa/b by Go¨ 6976 did not affect Ezrin phosphorylation. (B) Inhibition of aPKC by PSI reduced the
level of p-Ezrin in eight-cell embryos. *: PSI treatment caused extensive embryo death. Out of 30 PSI treated two-cell embryos, only 6 embryos developed to the eight-cell
embryo stage. Nevertheless, the level of p-Ezrin in all six surviving eight-cell embryos was decreased, compared to control embryos. (C) Control or aPKC siRNAs, together
with H2B-cherry mRNA, were injected into one blastomere of two-cell embryos. The injected embryos were cultured until compaction, and then subjected to
immunoﬂuorescence staining. Confocal images showed that the level of p-Ezrin was lower in eight-cell blastomere progeny of the aPKC siRNA injected cell (marked with
H2B-cherry signals) than in the blastomeres without siRNA injection. Bar, 20 mm and (D) A working model for embryo compaction. Rho GTPases facilitate the apical
distribution of Ezrin and aPKC. Next, Mek/Erk cooperates with the Ezrin kinase aPKC to promote the phosphorylation of Ezrin. Subsequently, phosphorylated Ezrin
stabilizes the apically enriched F-actin, allowing embryos to further development.
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development. Consistently, PD98059 and Ro-31-8220 do not
affect embryo development, even though both of them reduce
the p-Ezrin level at the apical region of eight-cell embryos. We did
not examine whether PD98059 and Ro-31-8220 treatment could
affect embryo development at later stages, because these inhibi-
tors might impair embryo development through other mechan-
isms in addition to Ezrin phosphorylation. It has been
demonstrated that embryos treated with PD98059 from the
eight-cell stage show a marked developmental delay in blastocoel
formation. This defect might be attributed to the reduced expres-
sion of a key trophectodermal transcription factor Cdx2 (Lu et al.,
2008). Decreased Ezrin phosphorylation might also contribute to
the developmental delay.
Despite the important role of Ezrin phosphorylation at T567 in
embryo compaction (Dard et al., 2004), it is not clear which kinase
is responsible for Ezrin phosphorylation during embryo com-
paction. Our data suggest that aPKC might phosphorylate Ezrin in
eight-cell embryos. First, it has been demonstrated that Rho-
associated kinases and various subtypes of PKC phosphorylate the
conserved threonine in the ERM proteins in vitro and in cultured
cells (Chuan et al., 2006; Matsui et al., 1998; Ng et al., 2001;
Oshiro et al., 1998; Pietromonaco et al., 1998; Shaw et al., 1998;
Simons et al., 1998; Wald et al., 2008). In C3-transferase treated
embryos, co-localization of aPKC, p-Ezrin and F-actin at thebasolateral cortex implicates that aPKC might be the Ezrin kinase
or a factor associated with the Ezrin kinase. Second, inhibition of
PKC by Ro-31-8220 or PSI, but not by the PKCa/b inhibitor Go¨
6976, reduces the overall level of p-Ezrin in eight-cell embryos.
Moreover, simultaneous downregulation of PKCl and PKCz by
siRNA injection reduces the level of p-Ezrin in eight-cell blasto-
mere progenies of the injected cell. In addition, depletion of PKCl
does not affect embryo compaction and blastomere polarization
at the eight-cell stage, but impaired the stabilization of cell
polarity at the 16-cell stage (Dard et al., 2009). This phenotype
is very similar to the defect caused by Ezrin-T567A mutant (Dard
et al., 2004). Consistently, Ezrin is detected in the basolateral area
in PKCl depleted 16-cell embryos, implying that Ezrin is not
efﬁciently phosphorylated in these embryos (Dard et al., 2009).
Third, we showed that PKC, but not Rho GTPases or Mek/Erk, is
required for maintaining the level of p-Ezrin in compacted
embryos. All these data support that aPKC is the Ezrin kinase in
eight-cell embryos.
In addition to aPKC, we also demonstrated that other signaling
pathways, including Rho GTPases and Mek/Erk, regulate Ezrin
phosphorylation in eight-cell embryos. During normal embryo
development, p-Ezrin appears in the apical region of compacted
eight-cell embryos, and persists throughout the rest of preim-
plantation embryogenesis. Inhibition of Rho GTPases changes the
distribution of Ezrin, p-Ezrin and aPKC, from the apical surface to
H. Liu et al. / Developmental Biology 375 (2013) 13–22 21the basolateral region. Aberrantly localized p-Ezrin leads to
F-actin formation at the basolateral region, which might interfere
with the formation of tight junctions at the basolateral region,
hence preventing embryo compaction. These data suggest that
Rho GTPases facilitate polarized distribution of Ezrin and aPKC
during embryo compaction. More investigations are required to
understand how Rho GTPases regulate Ezrin and aPKC polariza-
tion. Our data also implied that Mek/Erk signaling is involved in
Ezrin phosphorylation, as inhibition of Mek/Erk prevents the
phosphorylation of Ezrin T567 in eight-cell embryos. However,
inhibition of Mek/Erk does not interfere with the polarization
of Ezrin and aPKC. Therefore, Mek/Erk appears to act at a step
between aPKC/Ezrin polarization and Ezrin phosphorylation.
Given that Mek/Erk activity is not required for the mainte-
nance of p-Ezrin in compacted embryos, Mek/Erk might reg-
ulate the activity of the Ezrin kinase aPKC in compacting
embryos. Once aPKC is activated in compacted embryos,
Mek/Erk becomes dispensable for Ezrin phosphorylation.
Alternatively, Mek/Erk might facilitate the interaction between
aPKC and Ezrin to promote Ezrin phosphorylation by aPKC.
How Mek/Erk regulates Ezrin phosphorylation catalyzed by
aPKC during compaction remains to be elucidated.
Taken together, we propose a working model for these events
during embryo compaction (Fig. 6D). During eight-cell embryo
compaction, activation of Rho GTPases may facilitate the apical
distribution of aPKC and Ezrin. Meanwhile, aPKC and Mek/Erk
work together to promote Ezrin phosphorylation at the apical
region. The involvement of multiple signaling pathways in reg-
ulating Ezrin phosphorylation allows better temporal and spatial
control of the Ezrin kinase activity. Coincidently, during normal
embryo development, molecules mediating PKC and Mek/Erk
signaling, such as PKCz and Erk2, localize to the apical region
of eight-cell embryos, restricting the Ezrin kinase activity to
the apical region (Lu et al., 2008; Pauken and Capco, 2000).
Thus, Ezrin is only phosphorylated at the apical cortex. Phos-
phorylated Ezrin mediates the apical enrichment of F-actin, stabiliz-
ing the polarized apical region and securing normal embryo
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